�� News - stem cells

Stem cells and the future of health care - The Globe and Mail, December 8, 2021

webfull — Fri, 10 Dec 2021 00:01:09 +0000

Professor Jonathan Kimmelman, Director of the Biomedical Ethics Unit, participated in a Globe and Mail panel on stem cells.

Learn more and watch the recording.

Published: 9 December 2021

How Canadian researchers are using stem cell advances to transform medicine - The Globe and Mail, December 2, 2021

webfull — Fri, 03 Dec 2021 23:55:49 +0000

Professor Jonathan Kimmelman, Director of the Biomedical Ethics Unit, is among the experts quoted by The Globe and Mail.

Published: 3 December 2021

Major European grant backs �� research on rare condition

webfull — Wed, 27 Jan 2021 21:46:58 +0000

The European Joint Programme on Rare Diseases (EJP RD) has granted 1.6 million euros in support of an international research collaboration specific to the ultra-rare genetic disease, Schinzel-Giedion Syndrome (SGS). The international team of researchers is coordinated by the Douglas Research Centre and ��’s Associate Professor and Canada Research Chair in Psychiatric Genetics, Carl Ernst. The EJP RD is a joint program between major funding bodies from over 25 countries, including the CIHR and FRQS.

Published: 27 January 2021

Brain tumour awareness week

webfull — Mon, 22 Oct 2018 20:07:04 +0000

Providing excellent care and the latest research to help patients

The Brain Tumour Foundation of Canada estimates that 27 Canadians a day are diagnosed with a brain tumour and 55,000 are living with one. This Brain Tumour Awareness Week we recognize the toll this disease takes on patients and the work being done to improve their quality of life.

Published: 22 October 2018

The MNI forms promising Open Science partnership with Takeda

webfull — Mon, 04 Dec 2017 19:37:18 +0000

Industry and academia team up for the benefit of people suffering from ALS

A unique industry-academia partnership will increase the rate at which promising drug compounds can be tested as potential treatments for amyotrophic lateral sclerosis (ALS), a disease with no known cure that affects 200,000 people worldwide.

The partnership between The Montreal Neurological Institute and Hospital (MNI) and Takeda Pharmaceutical Company Limited (Takeda) will allow compounds developed by Takeda scientists to be tested on cell lines produced at the MNI.

Published: 4 December 2017

Turning skin cells into brain cells

webfull — Tue, 16 May 2017 14:09:42 +0000

Microglia, critical to Alzheimer’s research, can now be produced artificially

The quest for better understanding of Alzheimer’s disease (AD) has a powerful new tool at its disposal — the ability to artificially generate brain cells that have been shown to play an important role in the disease function.

Published: 16 May 2017

MNI researchers receive funding to study ARSACS

webfull — Thu, 24 Nov 2016 16:53:44 +0000

Two researchers at the Montreal Neurological Institute and Hospital (MNI) of �� have received funding to study a devastating neurodegenerative disease that first appears in toddlers just as they are beginning to walk.

Published: 24 November 2016

Skin cells for research into Parkinson's

webfull — Thu, 02 Apr 2015 19:25:49 +0000

Millions of Canadians are affected by diseases of the brain such as ALS, Parkinson’s and brain tumours, for which there are limited treatments and no cures. By 2020, neurological conditions will become the leading cause of death and disability.

Published: 2 April 2015

Major advance in understanding risky but effective Multiple Sclerosis treatment

webfull — Tue, 26 Mar 2013 13:53:15 +0000

Powerful treatment improves patients’ lives and provides new insight into mechanisms of the disease

Published: 26 March 2013

�������� News - stem cells